Livzon Pharmaceutical reports latest share repurchase activity

Livzon Pharmaceutical Group announced its share repurchase activities for September 5, 2025. The company repurchased 72,990 A-shares on the Shenzhen Stock Exchange at prices ranging from RMB 40.51 to RMB 41.7 per share, for a total cost of RMB 2,999,471.1.

As of September 5, 2025, the total number of repurchased A-shares intended for cancellation but not yet cancelled stands at 72,990. The total number of issued A-shares remains 604,293,313, with no shares held in treasury.

The company confirmed that all repurchases were conducted in accordance with the Hong Kong Stock Exchange Listing Rules and the GEM Listing Rules, and all necessary information has been submitted. The initial issued H-shares total 299,807,117.